Tenascin‐X, collagen, elastin, and the Ehlers–Danlos syndrome
Open accessThe DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Abstract
Tenascin‐X is an extracellular matrix protein initially identified because the gene encoding it overlaps with the human CYP21B gene. Because studies of gene and protein function of other tenascins had been poorly predictive of essential functions in vivo, we used a genetic approach that critically relied on an understanding of the genomic locus to uncover an association between inactivating tenascin‐X mutations and novel recessive and dominant forms of Ehlers–Danlos syndrome (EDS). Tenascin‐X provides the first example of a gene outside of the fibrillar collagens and their processing enzymes that causes EDS. Tenascin‐X null mice recapitulate the skin findings of the human disease, confirming a causative role for this gene in EDS. Further evaluation of these mice showed that tenascin‐X is an important regulator of collagen deposition in vivo, suggesting a novel mechanism of disease in this form of EDS. Further studies suggest that tenascin‐X may do this through both direct and indirect interactions with the collagen fibril. Recent studies show that TNX effects on matrix extend beyond the collagen to the elastogenic pathway and matrix remodeling enzymes. Tenascin‐X serves as a compelling example of how human “experiments of nature” can guide us to an understanding of genes whose function may not be evident from their sequence or in vitro studies of their encoded proteins. © 2005 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Congenital adrenal hyperplasia
Speiser, P. W., & White, P. C. (2003) · New England Journal of Medicine · doi:10.1056/nejmra021561 · Cited by 1,405
A recessive form of the Ehlers-Danlos syndrome caused by tenascin-X deficiency
Schalkwijk, J., Zweers, M. C., Steijlen, P. M., Dean, W. B., Taylor, G., van Vlijmen, I. M., van Haren, B., Miller, W. L., & Bristow, J. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa002939 · Cited by 391
Self-citationGrumet, M., Hoffman, S., Crossin, K. L., & Edelman, G. M. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.23.8075 · Cited by 391 · cited 1×
“For clarity, the mammalian genes are now called tenascin-C (TNC, formerly cytotactin, hexabrachion), tenascin-R (TNR, restrictin, janusin), tenascin-X (TNX), and the recently described tenascin-W (TNW, also tenascin-N) [Grumet et al., 1985; Pearson et al., 1988; Morel et al., 1989; Rathjen et al., 1991; Matsumoto et a…”
BackgroundTenascin-X deficiency is associated with Ehlers-Danlos syndrome
Burch, G. H., Gong, Y., Liu, W., Dettman, R. W., Curry, C. J., Smith, L., Miller, W. L., & Bristow, J. (1997) · Nature Genetics · doi:10.1038/ng0997-104 · Cited by 366 · cited 3×
“While the number remains small [Burch et al., 1997; Schalkwijk et al., 2001; Lindor and Bristow, 2005], several generalizations about the clinical features can be made.”
BackgroundSelf-citationTenascin-X: a novel extracellular matrix protein encoded by the human XB gene overlapping P450c21B
Bristow, J., Tee, M., Gitelman, S., Mellon, S., & Miller, W. (1993) · The Journal of cell biology · doi:10.1083/jcb.122.1.265 · Cited by 302
Self-citationMao, J. R., Taylor, G., Dean, W. B., Wagner, D. R., Afzal, V., Lotz, J. C., Rubin, E. M., & Bristow, J. (2002) · Nature Genetics · doi:10.1038/ng850 · Cited by 261 · cited 9×
“Tnx null mice are”
BackgroundInfluentialSelf-citationWeber, P., Bartsch, U., Rasband, M. N., Czaniera, R., Lang, Y., Bluethmann, H., Margolis, R. U., Levinson, S. R., Shrager, P., Montag, D., et al. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-11-04245.1999 · Cited by 247 · cited 1×
“The findings that the TNC, TNR and TNC/TNR double knockout mice lack an overt phenotype was both surprising and disappointing[11-13], and it remains uncertain whether this occurs because the tenascins share redundant functions or whether their most important functions are not during development but in adult responses…”
BackgroundHaploinsufficiency of TNXB Is Associated with Hypermobility Type of Ehlers-Danlos Syndrome
Zweers, M. C., Bristow, J., Steijlen, P. M., Dean, W. B., Hamel, B. C., Otero, M., Kucharekova, M., Boezeman, J. B., & Schalkwijk, J. (2003) · The American Journal of Human Genetics · doi:10.1086/376564 · Cited by 242 · cited 2×
“isolated joint hypermobility, representing nearly two-thirds of heterozygous women in the families [27].”
BackgroundSelf-citationThe Ehlers-Danlos syndrome: on beyond collagens
Mao, J.-R., & Bristow, J. (2001) · Journal of Clinical Investigation · doi:10.1172/jci12881 · Cited by 233 · cited 1×
“responsible for other Ehlers–Danlos variants [Mao and Bristow, 2001].”
BackgroundSelf-citationMorel, Y., Bristow, J., Gitelman, S. E., & Miller, W. L. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.17.6582 · Cited by 158
Self-citationMechanism and consequences of the duplication of the human C4/P450c21/gene X locus
Gitelman, S. E., Bristow, J., & Miller, W. L. (1992) · Molecular and Cellular Biology · doi:10.1128/mcb.12.5.2124 · Cited by 106
Self-citationScherberich, A., Tucker, R. P., Samandari, E., Brown-Luedi, M., Martin, D., & Chiquet-Ehrismann, R. (2004) · Journal of Cell Science · doi:10.1242/jcs.00867 · Cited by 90 · cited 2×
“For clarity, the mammalian genes are now called tenascin-C (TNC, formerly cytotactin, hexabrachion), tenascin-R (TNR, restrictin, januscin), tenascin-X (TNX) and the recently described tenascin-W (TNW, also tenascin-N) [2-10].”
BackgroundAbundant adrenal-specific transcription of the human P450c21A “pseudogene.”
Bristow, J., Gitelman, S. E., Tee, M. K., Staels, B., & Miller, W. L. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)31473-x · Cited by 84
Self-citationTumour invasion and metastasis are promoted in mice deficient in tenascin‐X
Matsumoto, K., Takayama, N., Ohnishi, J., Ohnishi, E., Shirayoshi, Y., Nakatsuji, N., & Ariga, H. (2001) · Genes to Cells · doi:10.1046/j.1365-2443.2001.00482.x · Cited by 81
Matsumoto, K.-I., Arai, M., Ishihara, N., Ando, A., Inoko, H., & Ikemura, T. (1992) · Genomics · doi:10.1016/0888-7543(92)90438-x · Cited by 80 · cited 1×
“TNX gene [20].”
Tenascin‐X deficiency in autosomal recessive Ehlers–Danlos syndrome
Lindor, N. M., & Bristow, J. (2005) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.30671 · Cited by 67 · cited 2×
“While the number of TNX-deficient patients known world-wide remains small [25, 26], several generalizations about the clinical features can be made.”
BackgroundSelf-citation
Cited by
Collagen fibrillogenesis: fibronectin, integrins, and minor collagens as organizers and nucleators
Kadler, K. E., Hill, A., & Canty-Laird, E. G. (2008) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2008.06.008 · Cited by 756
Heart Valve Development: Regulatory Networks in Development and Disease
Combs, M. D., & Yutzey, K. E. (2009) · Circulation Research · doi:10.1161/circresaha.109.201566 · Cited by 455
Interstitial guidance of cancer invasion
G. Gritsenko, P., Ilina, O., & Friedl, P. (2012) · The Journal of Pathology · doi:10.1002/path.3031 · Cited by 349
Malfait, F., Castori, M., Francomano, C. A., Giunta, C., Kosho, T., & Byers, P. H. (2020) · Nature Reviews Disease Primers · doi:10.1038/s41572-020-0194-9 · Cited by 316
Grune, J., Beyhoff, N., Smeir, E., Chudek, R., Blumrich, A., Ban, Z., Brix, S., Betz, I. R., Schupp, M., Foryst-Ludwig, A., et al. (2018) · Hypertension · doi:10.1161/hypertensionaha.117.10360 · Cited by 292
Metadata
- Authors
- Bristow, J., Carey, W., Egging, D., & Schalkwijk, J.
- Venue
- American Journal of Medical Genetics Part C: Seminars in Medical Genetics
- Publisher
- Wiley
- Published
- 2005-11-08
- Volume
- 139C
- Issue
- 1
- Pages
- 24-30
- ISSN
- 1552-4868 (ISSN-L)
- 1552-4876
- OpenAlex
- W2030281969
- Cited by
- 123
- References
- 16
- FWCI
- 2.18
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.